HBEGF and glioblastoma: As such, ADAM8 upregulates the HB-EGF/EGFR signaling-mediated CCL2 expression of GBM cells under TMZ treatment, subsequently inducing TAMs recruitment, which further stimulates ADAM8 upregulation of GBM cells to induce TMZ chemoresistance.